AU628879B2 - Compounds for the treatment of urinary incontinence - Google Patents

Compounds for the treatment of urinary incontinence Download PDF

Info

Publication number
AU628879B2
AU628879B2 AU44394/89A AU4439489A AU628879B2 AU 628879 B2 AU628879 B2 AU 628879B2 AU 44394/89 A AU44394/89 A AU 44394/89A AU 4439489 A AU4439489 A AU 4439489A AU 628879 B2 AU628879 B2 AU 628879B2
Authority
AU
Australia
Prior art keywords
methyl
compound
general formula
diphenylacetamide
diphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44394/89A
Other languages
English (en)
Other versions
AU4439489A (en
Inventor
Bertil Valdemar Hansen
Sten Sture Kelfve
Henri Rene Mollberg
Bengt Christer Hans Sjogren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU4439489A publication Critical patent/AU4439489A/en
Application granted granted Critical
Publication of AU628879B2 publication Critical patent/AU628879B2/en
Assigned to KABI PHARMACIA AB reassignment KABI PHARMACIA AB Alteration of Name(s) in Register under S187 Assignors: PHARMACIA AB
Assigned to PHARMACIA AB reassignment PHARMACIA AB Alteration of Name(s) in Register under S187 Assignors: KABI PHARMACIA AB
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Discharge Heating (AREA)
  • Table Equipment (AREA)
  • Finger-Pressure Massage (AREA)
  • Dowels (AREA)
AU44394/89A 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence Ceased AU628879B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8804003 1988-11-04
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Publications (2)

Publication Number Publication Date
AU4439489A AU4439489A (en) 1990-05-10
AU628879B2 true AU628879B2 (en) 1992-09-24

Family

ID=20373858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44394/89A Ceased AU628879B2 (en) 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence

Country Status (22)

Country Link
EP (1) EP0367040B1 (zh)
JP (1) JPH02218652A (zh)
KR (1) KR900007407A (zh)
CN (1) CN1043700A (zh)
AT (1) ATE88460T1 (zh)
AU (1) AU628879B2 (zh)
CA (1) CA2001641A1 (zh)
DD (1) DD289467A5 (zh)
DE (1) DE68906122T2 (zh)
DK (1) DK544689A (zh)
ES (1) ES2054980T3 (zh)
FI (1) FI895229A0 (zh)
HU (1) HU202828B (zh)
IE (1) IE63480B1 (zh)
NO (1) NO894384L (zh)
NZ (1) NZ231243A (zh)
PH (1) PH27014A (zh)
PT (1) PT92189B (zh)
RU (1) RU1833370C (zh)
SE (1) SE8804003D0 (zh)
TW (1) TW197944B (zh)
ZA (1) ZA898385B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
ZA921292B (en) * 1991-02-25 1993-08-23 Lilly Co Eli Treatment of lower urinary tract disorders.
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
EP3288527B1 (en) * 2015-04-28 2020-02-19 Unilever PLC, a company registered in England and Wales under company no. 41424 of N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same
CN107531655B (zh) 2015-04-28 2021-03-12 荷兰联合利华有限公司 N-芳烷基羰基-哌嗪和n-芳烷基羰基-高哌嗪化合物以及包含它们的个人护理组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
AU4935390A (en) * 1989-02-14 1990-09-27 Fujisawa Pharmaceutical Co., Ltd. A novel substituted-acetamide compound and a process for the preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831892A (en) * 1956-03-22 1958-04-22 Searle & Co N-(3-isopropylaminopropyl) diphenyl-acetamide and processes
FR2319337A1 (fr) * 1975-07-30 1977-02-25 Fabre Sa Pierre Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire
FR2333501A2 (fr) * 1975-12-03 1977-07-01 Science Union & Cie Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2340724A2 (fr) * 1976-02-13 1977-09-09 Science Union & Cie Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant
FR2421891A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Obtention industrielle d'amides de la pyrrolidine ethyl amine
FR2421892A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Procede de synthese industrielle du n(n' ethyl pyrrolidino-2 methyl) aadiphenylahydroxy acetamide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
AU4935390A (en) * 1989-02-14 1990-09-27 Fujisawa Pharmaceutical Co., Ltd. A novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
HU895648D0 (en) 1990-01-28
DK544689A (da) 1990-05-05
RU1833370C (en) 1993-08-07
PT92189A (pt) 1990-05-31
ES2054980T3 (es) 1994-08-16
IE893398L (en) 1990-05-04
FI895229A0 (fi) 1989-11-03
ATE88460T1 (de) 1993-05-15
PH27014A (en) 1993-02-01
CN1043700A (zh) 1990-07-11
PT92189B (pt) 1995-07-18
KR900007407A (ko) 1990-06-01
EP0367040A1 (en) 1990-05-09
DK544689D0 (da) 1989-11-01
CA2001641A1 (en) 1990-05-04
EP0367040B1 (en) 1993-04-21
NO894384L (no) 1990-05-07
SE8804003D0 (sv) 1988-11-04
NO894384D0 (no) 1989-11-03
HUT51597A (en) 1990-05-28
HU202828B (en) 1991-04-29
JPH02218652A (ja) 1990-08-31
NZ231243A (en) 1994-03-25
ZA898385B (en) 1990-07-25
DE68906122D1 (de) 1993-05-27
IE63480B1 (en) 1995-05-03
AU4439489A (en) 1990-05-10
DE68906122T2 (de) 1997-05-22
TW197944B (zh) 1993-01-11
DD289467A5 (de) 1991-05-02

Similar Documents

Publication Publication Date Title
RU2351588C2 (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида и их применение в терапии
US4999377A (en) Chemical compounds
US4629739A (en) Substituted sulfonamidobenzamides and method of treating arrhythmias
US7601868B2 (en) Amine derivative
JP2007509846A (ja) テトラヒドロ−ナフタレンおよび尿素誘導体
EP0254532A1 (en) Amide derivatives
HU207988B (en) Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
WO2007017094A1 (en) Substituted benzyloxy-phenylmethylcarbamate derivatives
JP2502343B2 (ja) 薬学的に活性な置換ベンズアミド
US4510139A (en) Substituted aminobenzamides and their use as agents which inhibit lipoxygenase activity
DK163181B (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
AU628879B2 (en) Compounds for the treatment of urinary incontinence
EP0007206A1 (en) Phenethanolamines, their formulations, preparation and use
US5236956A (en) Compounds for the treatment of urinary incontinence
PL162318B1 (pl) Sposób wytwarzania nowych pochodnych piperydyny PL PL PL
JP4156799B2 (ja) フェニルアミノアルキルカルボン酸誘導体およびそれを含有する医薬組成物
AU4991999A (en) Methods and compounds for treating depression and other disorders
WO2007080109A1 (en) Substituded benzyloxy-phenylmethylurea derivatives
JPH021439A (ja) ジアミン化合物、その製法及び該化合物を含有する高血圧症及び炎症を治療するための医薬
EP0221958B1 (en) 3-aminopropyloxyphenyl derivatives their preparation and pharmaceutical compositions containing them
NZ202229A (en) Esters of aryloxypropanolamine derivatives and pharmaceutical compositions
SK138993A3 (en) Amidoalkyl - and imidoalkylpiperazines
KR100307845B1 (ko) 신규한n-아미노알킬-1-비페닐렌일-2-카르복스아미드신규한도파민수용체서브타입특이적리간드
US4647562A (en) Anti-spasmodic agents having three branch chains
US4766119A (en) Antispasmodic alkylated aminothioester derivatives